And it's bumping against resistance
| Hey Folks, Jeff Bishop here, | While the S&P 500 has been basically flat this year, one of my all-time-favorite "tactical" ideas has done the exact opposite… | From its November low, this stock has surged 148% in just three months — and it's done it in a steady, disciplined uptrend. | The only deviation was an even bigger surge in late January. | I alerted the stock twice in early December, and it delivered double-digit intraday moves both times… | In fact, it made double-digit same-day runs on all 13 alert days in 2025. | So what's behind all this momentum? | For starters, company insiders have been scooping up shares hand over fist… more than 375,000 since late November alone. | That's often the biggest tell in clinical-stage biotech. | Then there are the catalysts: | The company dosed its first patient in a pivotal Phase 3 trial 🧪
Its lead drug is targeting a $50 billion immunotherapy market
The FDA has granted Fast Track and Orphan Drug designations 🏆
CEO says statistical assessments imply a "high probability of technical success"
There's been word of "potential early commercial approval — possibly within 18 to 24 months"
| On top of that, the company has clinical collaborations with Roche and Regeneron, and recently secured a multimillion-dollar grant from the NIH. | After a nearly 4% pop yesterday, the stock is sitting right at recent resistance. | I'm watching closely to see if it breaks through today. | If you want the full breakdown — including the clinical data, insider activity, partnerships, analyst targets, and why I believe this setup is so compelling right now — you need to see this page immediately. | 👉View Today's Tactical Idea👈 | If 2025's alert days are anything to go by, today could shape up to be very exciting. | Take a few minutes to dig into this stock and get it on your radar as early as possible. | 📚And as always, remember to bookmark this link: | https://app.ragingbull.com/room/market-masters | That link is your ticket to free access to our trading room any time during the day. | No credit card needed to access… | No tricky downloads… | And absolutely no gimmicks. | I'll be LIVE at 11AM EST this morning (Tuesday) to run down all the hottest stocks out there → join me HERE. | Just a great place to talk stocks and find new ideas – and maybe a few friends along the way as well! | To Your Success, | | | DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results. | *PAID PROMOTION: The content above is a paid promotion. Sherwood Ventures receives compensation from the company or affiliate partners featured in this email. We are paid to distribute this content and have a financial interest in promoting these products or services. Sherwood Ventures is not responsible for any content hosted on third-party sites or your experience with third-party advertisers. It is the third party's responsibility to ensure compliance with applicable laws. We may hold positions in securities we discuss and may trade without notice. We make no guarantees or warranties about what is advertised and have no fiduciary duty to subscribers. Always consult a qualified financial professional before making investment decisions. |
|
|
|
| | | | | Update your email preferences or unsubscribe here © 2026 Bullseye Trades 62 Calef Hwy. #233
Lee, NH 03861, United States | | Terms of Service | |
|
|
|
|
|
Tidak ada komentar:
Posting Komentar